FDA Issues Guidance On Trials For Stroke-Treatment Devices
This article was originally published in The Gray Sheet
Neurothrombectomy device trials should be designed to show that stroke patients are more likely to have a good outcome with the device than with an established therapy, FDA advises in a June 18 guidance
You may also be interested in...
Concentric Medical averted a randomized clinical trial requirement for Merci Retriever by convincing FDA that a single-arm study backs 510(k) clearance of the embolic retrieval system
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.